Prenatal exposure to perfluoroalkyl substances and cord plasma lipid concentrations

Youping Tian1, Maohua Miao2, Honglei Ji2

  • 1National Management Office of Neonatal Screening Project for CHD, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China; NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Fudan University, 779 Old Hu Min Road, Shanghai, 200237, China.

Insights

Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) may lower newborn lipid levels. This study found associations between specific PFAS and reduced total cholesterol and HDL-C in cord blood, suggesting disruption of infant lipid metabolism.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pediatrics

Background:

  • Per- and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants with largely unknown effects on fetal development.
  • Prenatal exposure to environmental chemicals is a growing concern for infant health outcomes.
  • Lipid metabolism is crucial for neonatal development and long-term health.

Purpose of the Study:

  • To investigate the association between prenatal exposure to individual and multiple PFAS and cord blood lipid concentrations in newborns.
  • To assess the impact of specific PFAS compounds on total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) in neonates.
  • To evaluate the combined effects of a mixture of PFAS on neonatal lipid profiles.

Main Methods:

  • Prospective cohort study utilizing data from the Shanghai-Minhang Birth Cohort Study.
  • Analysis of maternal plasma for eleven PFAS at 12-16 weeks gestation and cord blood for four lipid parameters.
  • Application of multiple linear regression and Bayesian Kernel Machine Regression (BKMR) models to assess exposure-outcome associations.

Main Results:

  • Increased maternal concentrations of perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUdA), and perfluorotridecanoic acid (PFTrDA) were associated with decreased ln-transformed TC and HDL-C concentrations in cord blood.
  • Inverse associations were also observed between PFDA, PFUdA, or PFTrDA and cord TG and LDL-C levels.
  • A mixture of eight PFAS showed a suggestively inverse association with all ln-transformed lipid concentrations, with higher exposure linked to lower TC.

Conclusions:

  • Prenatal exposure to certain PFAS may negatively impact lipid metabolism in newborns.
  • Specific PFAS compounds are associated with reduced levels of key lipids in cord blood.
  • These findings highlight the potential endocrine-disrupting effects of PFAS on fetal lipid homeostasis and warrant further investigation.